CMV-induced pathology: Pathway and gene-gene interaction analysis

Experimental and Molecular Pathology

Volumn 97, Issue 1, 2014, Pages 154-165

  Melnick, Michael ^a   Deluca, Krysta A ^a   Jaskoll, Tina ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Cell signaling; Pathway analysis; Salivary gland; Tumor microenvironment

Indexed keywords

GEFITINIB;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CARCINOGENESIS; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; DRUG MECHANISM; FEMALE; GENE INTERACTION; GENETIC ASSOCIATION; MALIGNANT NEOPLASTIC DISEASE; MALIGNANT TRANSFORMATION; MATHEMATICAL MODEL; MOLECULAR GENETICS; MOLECULAR PATHOLOGY; MOUSE; NEWBORN; NONHUMAN;

CELL SIGNALING; PATHWAY ANALYSIS; SALIVARY GLAND; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOMA, MUCOEPIDERMOID; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; EPISTASIS, GENETIC; FEMALE; GENE EXPRESSION REGULATION; GENE REGULATORY NETWORKS; HUMANS; MICE; MICE, INBRED C57BL; MODELS, THEORETICAL; ORGAN CULTURE TECHNIQUES; PROTEIN KINASE INHIBITORS; QUINAZOLINES; SALIVARY GLAND NEOPLASMS; SALIVARY GLANDS; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

EID: 84903834527     PISSN: 00144800     EISSN: 10960945     Source Type: Journal    
DOI: 10.1016/j.yexmp.2014.06.011     Document Type: Article

References (71)

1. Aderem A., Adkins J.N., Ansong C., Galagan J., Kaiser S., Korth M.J., Law G.L., McDermott J.G., Proll S.C., Rosenberger C., Schoolnik G., Katze M.G. A systems biology approach to infectious disease research: innovating the pathogen-host research paradigm. MBio 2011, 2(1):e00325-00310.
2. Akiyama R., Kawakami H., Taketo M.M., Evans S.M., Wada N., Petryk A., Kawakami Y. Distinct populations within Isl1 lineages contribute to appendicular and facial skeletogenesis through the β-catenin pathway. Dev. Biol. 2014, 387(1):37-48.
3. Bigelow R.L., Jen E.Y., Delehedde M., Chari N.S., McDonnell T.J. Sonic hedgehog induces epidermal growth factor dependent matrix infiltration in HaCaT keratinocytes. J. Invest. Dermatol. 2005, 124(2):457-465.
4. Boppana S.B., Fowler K.B. Persistence in the Population: Epidemiology and Transmission 2007, Cambridge University, Cambridge, MA.
5. Cerliani J.P., Vanzulli S.I., Piñero C.P., Bottino M.C., Sahores A., Nuñez M., Varchetta R., Martins R., Zeitlin E., Hewitt S.M., Molinolo A.A., Lanari C., Lamb C.A. Associated expressions of FGFR-2 and FGFR-3: from mouse mammary gland physiology to human breast cancer. Breast Cancer Res. Treat. 2012, 133(3):997-1008.
6. Cortez E., Roswall P., Pietras K. Functional subsets of mesenchymal cell types in the tumor microenvironment. Semin. Cancer Biol. 2014, 25C:3-9.
7. Daǧ F., Dölken L., Holzki J., Drabig A., Weingärtner A., Schwerk J., Lienenklaus S., Conte I., Geffers R., Davenport C., Rand U., Köster M., Weiß S., Adler B., Wirth D., Messerle M., Hauser H., Cičin-Šain L. Reversible silencing of cytomegalovirus genomes by type I interferon governs virus latency. PLoS Pathog. 2014, 10(2):e1003962.
8. Degnin C.R., Laederich M.B., Horton W.A. Ligand activation leads to regulated intramembrane proteolysis of fibroblast growth factor receptor 3. Mol. Biol. Cell 2011, 22(20):3861-3873.
9. Egeblad M., Nakasone E.S., Werb Z. Tumors as organs: complex tissues that interface with the entire organism. Dev. Cell 2010, 18(6):884-901.
10. Engelman J.A., Settleman J. Acquired resistance to tyrosine kinase inhibitors during cancer therapy. Curr. Opin. Genet. Dev. 2008, 18(1):73-79.
11. Eswarakumar V.P., Lax I., Schlessinger J. Cellular signaling by fibroblast growth factor receptors. Cytokine Growth Factor Rev. 2005, 16(2):139-149.
12. Giuliani A., Filippi S., Bertolaso M. Why network approach can promote a new way of thinking in biology. Front. Genet. 2014, 5:83.
13. Götschel F., Berg D., Gruber W., Bender C., Eberl M., Friedel M., Sonntag J., Rüngeler E., Hache H., Wierling C., Nietfeld W., Lehrach H., Frischauf A., Schwartz-Albiez R., Aberger F., Korf U. Synergism between Hedgehog-GLI and EGFR signaling in Hedgehog-responsive human medulloblastoma cells induces downregulation of canonical Hedgehog-target genes and stabilized expression of GLI1. PLoS One 2013, 8(6):e65403.
14. Hai B., Yang Z., Millar S.E., Choi Y.S., Taketo M.M., Nagy A., Liu F. Wnt/β-catenin signaling regulates postnatal development and regeneration of the salivary gland. Stem Cells Dev. 2010, 19(11):1793-1801.
15. Han J.D., Bertin N., Hao T., Goldberg D.S., Berriz G.F., Zhang L.V., Dupuy D., Walhout A.J., Cusick M.E., Roth F.P., Vidal M. Evidence for dynamically organized modularity in the yeast protein-protein interaction network. Nature 2004, 430(6995):88-93.
16. Hanahan D. Rethinking the war on cancer. Lancet 2014, 383(9916):558-563.
17. Hanahan D., Coussens L.M. Accessories to the crime: functions of cells recruited to the tumor microenvironment. Cancer Cell 2012, 21(3):309-322.
18. Heldin C.H. Targeting the PDGF signaling pathway in tumor treatment. Cell Commun. Signal. 2013, 11:97.
19. Herrera-Abreu M.T., Pearson A., Campbell J., Shnyder S.D., Knowles M.A., Ashworth A., Turner N.C. Parallel RNA interference screens identify EGFR activation as an escape mechanism in FGFR3-mutant cancer. Cancer Discov. 2013, 3(9):1058-1071.
20. Ho H.K., Yeo A.H., Kang T.S., Chua B.T. Current strategies for inhibiting FGFR activities in clinical applications: opportunities, challenges and toxicological considerations. Drug Discov. Today 2014, 19(1):51-62.
21. Huang S. On the intrinsic inevitability of cancer: from foetal to fatal attraction. Semin. Cancer Biol. 2011, 21(3):183-199.
22. Issa A., Gill J.W., Heideman M.R., Sahin O., Wiemann S., Dey J.H., Hynes N.E. Combinatorial targeting of FGF and ErbB receptors blocks growth and metastatic spread of breast cancer models. Breast Cancer Res. 2013, 15(1):R8.
23. Iwatsuki K., Liu H.X., Grónder A., Singer M.A., Lane T.F., Grosschedl R., Mistretta C.M., Margolskee R.F. Wnt signaling interacts with Shh to regulate taste papilla development. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(7):2253-2258.
24. Jakob J.A., Kies M.S., Glisson B.S., Kupferman M.E., Liu D.D., Lee J.J., El-Naggar A.K., Gonzalez-Angulo A.M., Blumenschein G.R. A phase II study of gefitinib in patients with advanced salivary gland cancers. Head Neck 2014, 10.1002/hed.23647.
25. Jaskoll T., Leo T., Witcher D., Ormestad M., Astorga J., Bringas P., Carlsson P., Melnick M. Sonic hedgehog signaling plays an essential role during embryonic salivary gland epithelial branching morphogenesis. Dev. Dyn. 2004, 229(4):722-732.
26. Jaskoll T., Witcher D., Toreno L., Bringas P., Moon A.M., Melnick M. FGF8 dose-dependent regulation of embryonic submandibular salivary gland morphogenesis. Dev. Biol. 2004, 268(2):457-469.
27. Jaskoll T., Abichaker G., Witcher D., Sala F.G., Bellusci S., Hajihosseini M.K., Melnick M. FGF10/FGFR2b signaling plays essential roles during in vivo embryonic submandibular salivary gland morphogenesis. BMC Dev. Biol. 2005, 5:11.
28. Jaskoll T., Htet K., Abichaker G., Kaye F.J., Melnick M. CRTC1 expression during normal and abnormal salivary gland development supports a precursor cell origin for mucoepidermoid cancer. Gene Expr. Patterns 2011, 11(1-2):57-63.
29. Johnston C.L., Cox H.C., Gomm J.J., Coombes R.C. Fibroblast growth factor receptors (FGFRs) localize in different cellular compartments. A splice variant of FGFR-3 localizes to the nucleus. J. Biol. Chem. 1995, 270(51):30643-30650.
30. Katoh Y., Katoh M. Hedgehog signaling, epithelial-to-mesenchymal transition and miRNA (review). Int. J. Mol. Med. 2008, 22(3):271-275.
31. Kirouac D.C., Du J.Y., Lahdenranta J., Overland R., Yarar D., Paragas V., Pace E., McDonagh C.F., Nielsen U.B., Onsum M.D. Computational modeling of ERBB2-amplified breast cancer identifies combined ErbB2/3 blockade as superior to the combination of MEK and AKT inhibitors. Sci. Signal. 2013, 6(288):ra68.
32. Kono S.A., Marshall M.E., Ware K.E., Heasley L.E. The fibroblast growth factor receptor signaling pathway as a mediator of intrinsic resistance to EGFR-specific tyrosine kinase inhibitors in non-small cell lung cancer. Drug Resist. Updat. 2009, 12(4-5):95-102.
33. Krejci P., Aklian A., Kaucka M., Sevcikova E., Prochazkova J., Masek J.K., Mikolka P., Pospisilova T., Spoustova T., Weis M., Paznekas W.A., Wolf J.H., Gutkind J.S., Wilcox W.R., Kozubik A., Jabs E.W., Bryja V., Salazar L., Vesela I., Balek L. Receptor tyrosine kinases activate canonical WNT/β-catenin signaling via MAP kinase/LRP6 pathway and direct β-catenin phosphorylation. PLoS One 2012, 7(4):e35826.
34. Lieberman P.M. Virology. Epstein-Barr virus turns 50. Science 2014, 343(6177):1323-1325.
35. Lujan B., Hakim S., Moyano S., Nadal A., Caballero M., Diaz A., Valera A., Carrera M., Cardesa A., Alos L. Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands. Br. J. Cancer 2010, 103(4):510-516.
36. Marsh T., Pietras K., McAllister S.S. Fibroblasts as architects of cancer pathogenesis. Biochim. Biophys. Acta 2013, 1832(7):1070-1078.
37. Marshall M.E., Hinz T.K., Kono S.A., Singleton K.R., Bichon B., Ware K.E., Marek L., Frederick B.A., Raben D., Heasley L.E. Fibroblast growth factor receptors are components of autocrine signaling networks in head and neck squamous cell carcinoma cells. Clin. Cancer Res. 2011, 17(15):5016-5025.
38. Mavila N., James D., Utley S., Cu N., Coblens O., Mak K., Rountree C.B., Kahn M., Wang K.S. Fibroblast growth factor receptor-mediated activation of AKT-β-catenin-CBP pathway regulates survival and proliferation of murine hepatoblasts and hepatic tumor initiating stem cells. PLoS One 2012, 7(11):e50401.
39. Melnick M., Jaskoll T. Mouse submandibular gland morphogenesis: a paradigm for embryonic signal processing. Crit. Rev. Oral Biol. Med. 2000, 11(2):199-215.
40. Melnick M., Mocarski E.S., Abichaker G., Huang J., Jaskoll T. Cytomegalovirus-induced embryopathology: mouse submandibular salivary gland epithelial-mesenchymal ontogeny as a model. BMC Dev. Biol. 2006, 6:42.
41. Melnick M., Phair R.D., Lapidot S.A., Jaskoll T. Salivary gland branching morphogenesis: a quantitative systems analysis of the Eda/Edar/NFkappaB paradigm. BMC Dev. Biol. 2009, 9:32.
42. Melnick M., Abichaker G., Htet K., Sedghizadeh P., Jaskoll T. Small molecule inhibitors of the host cell COX/AREG/EGFR/ERK pathway attenuate cytomegalovirus-induced pathogenesis. Exp. Mol. Pathol. 2011, 91(1):400-410.
43. Melnick M., Sedghizadeh P.P., Allen C.M., Jaskoll T. Human cytomegalovirus and mucoepidermoid carcinoma of salivary glands: cell-specific localization of active viral and oncogenic signaling proteins is confirmatory of a causal relationship. Exp. Mol. Pathol. 2012, 92(1):118-125.
44. Melnick M., Deluca K.A., Sedghizadeh P.P., Jaskoll T. Cytomegalovirus-induced salivary gland pathology: AREG, FGF8, TNF-α, and IL-6 signal dysregulation and neoplasia. Exp. Mol. Pathol. 2013, 94(2):386-397.
45. Melnick M., Sedghizadeh P.P., Deluca K.A., Jaskoll T. Cytomegalovirus-induced salivary gland pathology: resistance to kinase inhibitors of the upregulated host cell EGFR/ERK pathway is associated with CMV-dependent stromal overexpression of IL-6 and fibronectin. Herpesviridae 2013, 4:1.
46. Mitchell M. Complexity: A Guided Tour 2009, Oxford University Press, New York.
47. Mora A., Taranta M., Zaki N., Badidi E., Cinti C., Capobianco E. Ensemble inference by integrative cancer networks. Front. Genet. 2014, 5:59.
48. Nichols W.G., Boeckh M. Recent advances in the therapy and prevention of CMV infections. J. Clin. Virol. 2000, 16(1):25-40.
49. Oliveras-Ferraros C., Cufí S., Queralt B., Vazquez-Martin A., Martin-Castillo B., de Llorens R., Bosch-Barrera J., Brunet J., Menendez J.A. Cross-suppression of EGFR ligands amphiregulin and epiregulin and de-repression of FGFR3 signalling contribute to cetuximab resistance in wild-type KRAS tumour cells. Br. J. Cancer 2012, 106(8):1406-1414.
50. Onnela J.P. Physics. Flow of control in networks. Science 2014, 343(6177):1325-1326.
51. Patel N., Sharpe P.T., Miletich I. Coordination of epithelial branching and salivary gland lumen formation by Wnt and FGF signals. Dev. Biol. 2011, 358(1):156-167.
52. Pietras K., Ostman A. Hallmarks of cancer: interactions with the tumor stroma. Exp. Cell Res. 2010, 316(8):1324-1331.
53. Reid B.S., Yang H., Melvin V.S., Taketo M.M., Williams T. Ectodermal Wnt/β-catenin signaling shapes the mouse face. Dev. Biol. 2011, 349(2):261-269.
54. Reinchisi G., Parada M., Lois P., Oyanadel C., Shaughnessy R., Gonzalez A., Palma V. Sonic hedgehog modulates EGFR dependent proliferation of neural stem cells during late mouse embryogenesis through EGFR transactivation. Front. Cell. Neurosci. 2013, 7:166.
55. Robinson K.W., Sandler A.B. EGFR tyrosine kinase inhibitors: difference in efficacy and resistance. Curr. Oncol. Rep. 2013, 15(4):396-404.
56. Ruths J., Ruths D. Control profiles of complex networks. Science 2014, 343(6177):1373-1376.
57. Schwarz S., Stiegler C., Müller M., Ettl T., Brockhoff G., Zenk J., Agaimy A. Salivary gland mucoepidermoid carcinoma is a clinically, morphologically and genetically heterogeneous entity: a clinicopathological study of 40 cases with emphasis on grading, histological variants and presence of the t(11;19) translocation. Histopathology 2011, 58(4):557-570.
58. Sinor-Anderson A., Lillien L. Akt1 interacts with epidermal growth factor receptors and hedgehog signaling to increase stem/transit amplifying cells in the embryonic mouse cortex. Dev. Neurobiol. 2011, 71(9):759-771.
59. Su W., Meng F., Huang L., Zheng M., Liu W., Sun H. Sonic hedgehog maintains survival and growth of chronic myeloid leukemia progenitor cells through β-catenin signaling. Exp. Hematol. 2012, 40(5):418-427.
60. Sütterlin P., Williams E.J., Chambers D., Saraf K., von Schack D., Reisenberg M., Doherty P., Williams G. The molecular basis of the cooperation between EGF, FGF and eCB receptors in the regulation of neural stem cell function. Mol. Cell. Neurosci. 2013, 52:20-30.
61. Wagner R.P., Tian H., McPherson M.J., Latham P.S., Orenstein J.M. AIDS-associated infections in salivary glands: autopsy survey of 60 cases. Clin. Infect. Dis. 1996, 22(2):369-371.
62. Wang Y., Song L., Zhou C.J. The canonical Wnt/β-catenin signaling pathway regulates Fgf signaling for early facial development. Dev. Biol. 2011, 349(2):250-260.
63. Wang Y.N., Lee H.H., Lee H.J., Du Y., Yamaguchi H., Hung M.C. Membrane-bound trafficking regulates nuclear transport of integral epidermal growth factor receptor (EGFR) and ErbB-2. J. Biol. Chem. 2012, 287(20):16869-16879.
64. Ware K.E., Marshall M.E., Heasley L.R., Marek L., Hinz T.K., Hercule P., Helfrich B.A., Doebele R.C., Heasley L.E. Rapidly acquired resistance to EGFR tyrosine kinase inhibitors in NSCLC cell lines through de-repression of FGFR2 and FGFR3 expression. PLoS One 2010, 5(11):e14117.
65. Ware K.E., Hinz T.K., Kleczko E., Singleton K.R., Marek L.A., Helfrich B.A., Cummings C.T., Graham D.K., Astling D., Tan A.C., Heasley L.E. A mechanism of resistance to gefitinib mediated by cellular reprogramming and the acquisition of an FGF2-FGFR1 autocrine growth loop. Oncogenesis 2013, 2:e39.
66. Watts D.J., Strogatz S.H. Collective dynamics of 'small-world' networks. Nature 1998, 393(6684):440-442.
67. Wilson T.R., Fridlyand J., Yan Y., Penuel E., Burton L., Chan E., Peng J., Lin E., Wang Y., Sosman J., Ribas A., Li J., Moffat J., Sutherlin D.P., Koeppen H., Merchant M., Neve R., Settleman J. Widespread potential for growth-factor-driven resistance to anticancer kinase inhibitors. Nature 2012, 487(7408):505-509.
68. Wiseman B.S., Werb Z. Stromal effects on mammary gland development and breast cancer. Science 2002, 296(5570):1046-1049.
69. Young L.S., Rickinson A.B. Epstein-Barr virus: 40years on. Nat. Rev. Cancer 2004, 4(10):757-768.
70. Yuan J., Liu X., Wu A.W., McGonagill P.W., Keller M.J., Galle C.S., Meier J.L. Breaking human cytomegalovirus major immediate-early gene silence by vasoactive intestinal peptide stimulation of the protein kinase A-CREB-TORC2 signaling cascade in human pluripotent embryonal NTera2 cells. J. Virol. 2009, 83(13):6391-6403.
71. Zammit C., Barnard R., Gomm J., Coope R., Shousha S., Coombes C., Johnston C. Altered intracellular localization of fibroblast growth factor receptor 3 in human breast cancer. J. Pathol. 2001, 194(1):27-34.